Traphagen Investment Advisors LLC Baxter International Inc Transaction History

Traphagen Investment Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jun 17, 2024	SELL	$76.85 - $89.45 $187,590 - $218,347	-2,441 Closed	0 $0
Q4 2021 Jun 17, 2024	BUY	$74.57 - $87.19 $182,025 - $212,830	2,441 New	2,441 $210 Million
Q3 2021 Jun 17, 2024	SELL	$73.77 - $83.61 $147 - $167	-2 Reduced 0.21%	952 $234 Million
Q2 2021 Jun 17, 2024	SELL	$80.5 - $88.01 $2,737 - $2,992	-34 Reduced 3.44%	954 $232 Million
Q1 2021 Jun 17, 2024	BUY	$76.38 - $86.03 $75,463 - $84,997	988 New	988 $240 Million
Q4 2020 Jun 17, 2024	SELL	$75.39 - $82.36 $6,257 - $6,835	-83 Reduced 7.09%	1,087 $272 Million
Q3 2020 Jun 17, 2024	SELL	$78.33 - $90.73 $99,557 - $115,317	-1,271 Reduced 52.07%	1,170 $272 Million
Q2 2020 Jun 17, 2024	BUY	$78.66 - $94.14 $192,009 - $229,795	2,441 New	2,441 $210 Million
Q4 2019 Jun 17, 2024	BUY	$76.7 - $88.45 $187,224 - $215,906	2,441 New	2,441 $204 Million
Q3 2019 Jun 17, 2024	BUY	$81.4 - $89.78 $198,697 - $219,152	2,441 New	2,441 $214 Million

1,007

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Traphagen Investment Advisors LLC with notifications on news.